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Abstract. – OBJECTIVE: The aim of this study 
was to evaluate functionality and clinical applica-
tion of a novel immediate device in the treatment of 
temporomandibular disorders (TMDs). To address 
the research purpose, authors developed and im-
plemented a randomized control clinical trial.
PATIENTS AND METHODS: Eighty patients 
were enrolled in this study and were randomly di-
vided into two subgroups based on the treatment 
applied: patient group (PG) and control group (CG). 
The CG was not subjected to any kind of treatment, 
even placebo, in order to be able to assess the 
spontaneous development of the pathology over 
time. The PG was treated applying the novel device 
for a maximum of three months. The following pa-
rameters were evaluated at baseline (T0) and at the 
end of therapy (T1): presence/absence of articular 
noises, painful symptomatology (articular pains, 
muscle pains, headache, cervicalgia), parafunc-
tional habits and duration of symptoms. The x2-in-
dex of association was performed, with a p-value < 
0.05 considered as statistically significant.
RESULTS: No patient in the PG worsened its 
symptomatology. Thirteen patients (33%) declared 
themselves cured from their symptoms and were 
included in a monitoring protocol. Twenty-seven 
patients (67%) improved their symptoms and were 
treated with other conservative conventional 
methods to complete the therapeutic cycle. There-
fore, 100% of PG obtained benefits from the appli-
cation of the new therapeutic approach. In con-
trast, among patients of CG, eighteen subjects 
(45%) worsened their symptoms, while eighteen 
(45%) were defined as stationaries compared to T0 
and only four (10%) were defined as improved.
CONCLUSIONS: The device presented the fol-
lowing advantages: immediacy of use, reduction 
of waiting times for its application, good tolerabil-
ity and comfort and specificity in the execution of 
tongue rehabilitation exercises. 
Key Words
Temporomandibular disorders, TMJ, headache, Re-
ducible dislocation. 
Introduction
The tongue is an important organ for the 
harmonious development of the maxilla and reg-
ulation of mandibular movements1,2. An alteration 
of its functional and biomechanical patterns may 
involve occlusion, skeletal bases, TMJ (Temporo-
mandibular Joint) functions and oral and perioral 
muscles3,4. This organ is generally concerned by 
rehabilitation treatment for the correction of atyp-
ical swallowing in orthodontic therapy5. In the 
multidisciplinary management of TMDs, howev-
er, the myofunctional therapy of the tongue is still 
rarely considered, and traditional gnathological 
occlusal splints typically do not provide specific 
activities involving the tongue6,7.
Implant therapy is still controversial in pa-
tients affected by TMDs and parafunctional 
habits8,9: several authors10-12 have reported lower 
success and survival rates, when compared with 
standard patients, with a higher frequency of me-
chanical failures12,13 over implant-related biologic 
complications14-18. 
The aim of this work is to evaluate functional-
ity and clinical application of a novel immediate 
device. This Bite originates from the evolution 
of a similar apparatus that has already been 
studied, experimented and published by the same 
authors19,20. “The Lingual Ring Ri.P.A.Ra.”, there-
fore, represents the development of this research. 
This device distinguishes itself from the previous 
one by its peculiar and innovative structural char-
acteristics. “THE UNIRA” is a neuromuscular 
deconditioning indirect splint20, the “Ri.P.A.Ra.” 
has the purpose to re-educate either the mandib-
ular and tongue position in an active way through 
a specific functional ring.
Constructional, technical, mechanical, phys-
ical and functional characteristics of this novel 
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device are reported, presenting the preliminary 
results of its use on a sample of dysfunctional 




To address the research purpose, the authors 
developed and implemented a randomized control 
clinical study, to be conducted at the Department 
of Oral and Maxillo-Facial Sciences, at “Sapienza” 
University of Rome (Rome, Italy).
From February to December 2014, a con-
secutive series of 299 patients came to our 
observation at the Clinical Gnathology Unit. 
The Ethical Committee of the Department of 
Oral and Maxillo-Facial Sciences approved the 
study on 01-10-2014. All patients included in 
the study signed the informed consent form. 
Subjects underwent either clinical and instru-
mental examinations to analyze the presence of 
temporomandibular disorders (TMDs) in accor-
dance with the Research Diagnostic Criteria for 
Temporomandibular Disorders (DC/TMD)21,22. 
Patients were selected based on the following 
inclusion and exclusion criteria.
Inclusion criteria:
 • Reducible dislocation of the articular disk 
 • Sub-acute and chronic myalgia ≥ 30 
 • Arthralgia ≥ 30 values NVS (Numeric Verbal 
Scale)
 • Parafunctional habits associated with muscu-
lar and/or articular pains 
 • Comorbidity with tensive headache and/or mi-
graine ≥ 30 NVS values 
 • Comorbidity with cervicalgia and/or spine 
pain of tensive origin ≥ 30 NVS values
 • Committed to participate to the entire du-
ration of the study and signed the informed 
consent form.
Exclusion criteria:
 • Other disorders inserted in the DC
 • Axis II positivity
 • Outcomes or consequences of condylar frac-
tures and/or of any other maxillofacial district
 • Patients subjected to surgical therapy of TMJ
 • Patients already under therapy for the same 
disorders
 • Articular disorders of systemic nature (rheu-
matoid arthritis, arthrosis, psoriatic arthritis)
 • Known pathologies of a neurological and/or psy-
chic nature including other forms of headache
 • More than 8 missing teeth 
Out of the 299 visited patients, 219 were not 
included because they did not meet the above-
mentioned criteria. In detail, reasons for exclusion 
were the following: 32 suffered from chronic lock; 
27 were Axis II positive; 13 were outcomes of 
fractures; 59 had pain with NVS values < 30; 13 
had multiple missing teeth; 14 refused to be en-
rolled in the study, and 89 were subjected to other 
treatments. 
The selected sample, therefore, consisted of 80 
patients, randomly divided into two subgroups: 
patient group (PG) and control group (CG). All 
subjects signed the informed consent form and 
agreed to be included in the study.
The CG was not subjected to any treatment, 
even placebo, in order to be able to assess the 
spontaneous development of the pathology over 
time. All patients were carefully examined in or-
der to obtain comparable results. To decrease the 
inter-examiner variability, all examinations were 
performed by the same two expert operators. 
Study Variables
The following parameters were evaluated be-
fore the beginning of therapy, defined as baseline 
(T0) and at the end of therapy (T1):
 • Presence/absence of articular noises, compat-
ible with a reducible dislocation of the disk
 • Painful symptomatology (articular pains, 
muscle pains, headache, cervicalgia) divided 
into 4 categories based on the value conferred 
upon them in terms of the NVS scale (Nu-
meric Verbal Scale): mild (0-30); moderate 
(30-50); strong (50-80); severe (80-100). 
 • Presence/absence of parafunctional habits
 • Duration of symptoms (months/years)
 • Medical examinations were planned every 25 
days, for either group. 
 • The following parameters were assessed at the 
end of therapy (T1):
 • duration of treatment (hours of application/
months of therapy)
 • Result of treatment expressed through the 
following categories:
H: healed, no sign no symptom
I: improved, at least one symptom improved and 
none worsened
S: stationary, no symptom improved no sign 
worsened
W: worsened, at least one symptom or one sign 
worsened and none improved.
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Statistical Analysis 
Descriptive statistics (mean, range) was 
computed for each variable of the study, col-
lected at baseline (T0) and at end of therapy 
(T1). The Chi-square index of association was 
performed to check that frequencies of values 
observed adapted to the theoretical frequencies 
of a predetermined probability distribution, 
with a p-value < 0.05 considered as statistically 
significant.
Functional characteristics 
of the new device
All patients were informed of the aims of the 
study and authors specified them that a novel 
device would be applied free of charge. 
A medical platinic silicone, non-toxic, hypo-
allergenic, biocompatible, in compliance with 
regulation (UNI EN ISO 10993 1:2010) and the 
EU directives 93-42 EC (Class 1 medical devic-
es), hardness 55 Shore, was selected to fabricate 
the novel device (Lingual Ring Ri.P.A.Ra.). Its 
thickness is 3 mm in the occlusal portion sub-
jected to loads and 2 mm in the remaining 
parts. It is made of three different components 
(Figures 1-2):
1) Central part A, i.e., the real and proper Lin-
gual ring. 
2) Part B, i.e., the reinforcement, anchoring, bal-
ancing, fitting and stabilization systems. 
3) Part C, i.e., the functional reference rehabili-
tation systems.
 –  Part A is composed of two arches: Arch 
“1” below and arch “2” above, that extend 
laterally on two horizontal planes which 
are placed between the teeth: the “3d” 
plane on the right, and the “3s” plane on 
the left which are symmetrical (Figures 
1-2), all this constitutes the most important 
“Active” universal functional unit.
 –  Part B is formed by two symmetrical palatal 
vertical reinforcement edges “4d” on the right 
and “4s” on the left, two vertical lateral sym-
metrical balance cheek shields “5d” to the right 
and “5s” to the left, a front connection band “6”;
 –  Part C is the functional reference rehabil-
Figure 1. Lingual ring Ri.P.A.Ra (front view). Figure 2. Lingual ring Ri.P.A.Ra (rear view).
Figure 3. Patient with the lingual ring Ri.P.A.Ra inserted.
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itation system to stimulate active collabo-
ration on the part of the patient by means 
of specific exercises, can be inserted or not 
as follows: one or more reeducative circular 
buttons or similar elements depending on 
the size and morphology of the oral cavity 
and also according to the required rehabil-
itative action. 
Therefore, the illustrated device, by means of 
the Lingual Ring, basically aims at the positional 
rehabilitation of the tongue, the mandible and all 
components of the stomatognathic apparatus. 
Therapeutic indications
1. The therapeutic protocol of the Universal 
Splint “RI.P.A.RA.” is articulated in the fol-
lowing manner: 
2. Standardized prescription of application of the 
device from a minimum of night only and rest 
(6-8h), to a maximum of 12 hours per day, 
including night and rest, with the indication 
to put the tongue at the top of the spot and 
the cognitive information to not tighten on the 
horizontal planes (3d and 3s);
3. For the entire PG, the only therapeutic pre-
sidium was the RI.P.A.RA. device, which was 
not associated with any other form of therapy 
during the treatment period (1-3 months);
The maximum duration established for an entire 
cycle of treatment was 3 months. 
Results
The PG study sample was represented by a 
consecutive series of 40 patients: they were either 
males (6) and females (34), with a mean age of 34 
years (range: 20-58 years). 
The CG control group was composed by 40 
patients: 35 females and 5 males aged between 25 
and 51 years with a mean age of 38 years, with the 
same characteristics of the PG, but not subjected 
to any treatment for all intervention period. 
All patients of the two groups (Table I and Ta-
ble II) were suffering from a reducible dislocation 
of the articular disk. 
As the novel device is an immediate splint, 
application times were consistent with the type of 
splint and the evaluation of the expected results 
could not exceed three months.
TMJ noises, present in the totality of PG 
sample (40 patients; 100%), disappeared in 38 pa-
tients (95%) and were stationary in the remaining 
2 (5%). TMJ noises, in the CG, were present in 
the totality of sample at T0 (40 patients; 100%), 
and were unchanged at T1 in 39 patients (98%), 
disappearing only in 1 patient (3%).
As for the algic symptomatology, the follow-
ing characteristics were found out in the PG: TMJ 
pains, n=32 (80%); muscular pains, n=30 (75%); 
cervical pains, n=22 (55%); headache, n=33 
(82.5%); parafunctional habits, n=33 (82.5%). 
While for the CG, the following data were reg-
istered: TMJ pains, n=26 (65%); muscular pains, 
n=24 (60%); cervical pains, n=17 (43%); headache, 
n=28 (70%); parafunctional habits, n=32 (80%). 
The “articular pains” in the PG, initially pres-
ent in 32 patients, representing 80% of the sample, 
disappeared after application of the novel device 
in 25 patients (63%), being therefore absent in 33 
patients (83%) and remaining only in 7 patients 
(17%) at T1. However, all patients reported an 
improvement of their symptomatology and none 
any worsening. As for the CG (Table 4), the ar-
ticular pains present at T0 in 26 patients (65%) 
were stationary at T1 in 22 of these (85%), while 
4 patients (15%) had worsened.
The “muscular pains”, initially present in the 
PG in 30 patients (75%), disappeared in 17 patients 
(43%) and were present only in 13 patients (33%), 
with 10 indicating they had mild pain (77%) and 
3 moderate pain (23%). As regarding the CG (Ta-
ble 4), articular pains present at T0 in 24 patients 
(60% of the sample), were stationary at T1 in 23 
of these (96%), while one patient (4%) reported a 
worsening.
As for comorbidity, “headache”, present in the 
PG in 33 patients, 82.5% of the sample, had dis-
appeared in 16 patients (40%), and among the 17 
patients who still presented headache, 13 (76%) 
reported mild symptoms and 4 (24%) moderate. 
A headache in the CG was present in 28 patients 
(70%) at T0 and in 31 patients (78%) at T1, with 
a worsening of the previous symptomatology in 
3 patients (7.5% of the sample).
The “cervical pains”, initially present in PG in 
22 patients (55%), had disappeared in 12 patients 
(30%). Among the 7 patients who still presented 
cervicalgia (18%), all had mild symptoms (100%) 
with no worsening. As for the CG (Table 4), 
cervical algias present at T0 in 17 patients (43%) 
remained stationary at T1 with worsening in 1 
patient (6% of patients with cervicalgia).
As for “parafunctional habits” in PG: 27 pa-
tients (82%) reported feeling a weaker and dif-
ferent feeling when tightening their teeth and 
waking up in the morning with a lower muscular 
tension, which remained virtually unchanged in 
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6 cases (18%). For the CG, this parameter was 
present in 32 patients (80%) at T0 and at T1 had 
remained stationary in the same 32 patients.
As for treatment duration, expressed as “hours 
of daily application”: the average daily applica-
tion was 7 hours (range: 4-12 hours). As for “Ap-
plication Time”, expressed as months of therapy: 
the average time was 1.8 months in 22 patients 
(range: 1-3 months).
The following results (p<0.05) were expressed 
through segmentation analysis at T1 comparing 
both groups:
 PG         CG
Worsened 0 = 0% - 18 = 45%
Stationary 0 = 0% - 18 = 45%
Improved 27 = 68% - 4 = 10%
Cured 13 = 33% - 0 = 0% 
Discussion 
The vast majority of universal occlusal splints 
used in TMD therapy are designed to be simple 
“pads”, that counteract the load determined by 
the strength of the vertical muscles (masseters, 
Table I. Patients group at T0.
Patients Age Gender Articular  Articular Muscle Head- Cervi- Parafun- Duration
    noises  pains  pains  ache  calgia  ctional  of symp-
         habits    toms
                          (months/
                         years)
11 37 F YES 90 70 50 50 YES  4
 2 45 F YES 0 70 70 0 YES  2
 3 50 F YES 50 50 0 0 YES  1
 4 30 M YES 0 60 60 0 NO  3
 5 27 F YES 0 40 0 40 YES  1
 6 32 F YES 50 0 80 0 YES  3
 7 25 F YES 0 50 50 70 NO  6
 8 28 F YES 30 0 50 0 YES  1
 9 43 F YES 30 0 40 60 YES  1
10 51 F YES 50 50 50 0 NO  4
11 37 F YES 30 0 80 80 YES  1
12 38 F YES 0 60 40 0 YES  2
13 41 F YES 0 80 80 0 NO  3
14 50 F YES 60 0 0 50 YES  1
15 43 M YES 60 0 0 0 YES 9 
16 33 F YES 40 40 40 30 YES  1
17 28 F YES 60 0 0 0 YES  1
18 47 F YES 30 0 0 0 NO 6 
19 42 F YES 50 0 30 20 YES 8 
20 26 F YES 70 0 80 30 NO  1
21 42 F YES 0 70 70 0 YES 8 
22 41 F YES 0 40 50 40 YES  1
23 28 F YES 50 0 50 0 YES  2
24 33 F YES 60 40 0 0 YES  1
25 43 M YES 40 40 40 30 YES  2
26 50 F YES 80 50 0 50 YES 9 
27 43 F YES 80 0 0 0 YES  1
28 38 F YES 0 80 60 0 NO  3
29 37 M YES 0 60 40 70 YES  2
30 51 F YES 30 0 30 0 YES  1
31 44 F YES 50 50 50 90 YES  4
32 28 F YES 30 0 0 0 YES  1
33 25 F YES 30 0 50 0 YES  1
34 32 F YES 0 50 50 70 NO  6
35 27 F YES 50 0 80 0 YES  3
36 29 F YES 0 40 0 40 YES  1
37 51 F YES 0 60 90 0 YES  3
38 46 F YES 50 50 0 0 YES  1
39 38 M YES 0 70 70 0 YES  2
40 31 F YES 40 70 50 50 YES  4
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internal and temporal pterygoids); while, in this 
case, the lower part of the device (Lower Arch), 
guides the front repositioning of the mandible23-25. 
The new posture, in addition to altering the 
vertical dimension, stimulates the elongation of 
all muscles, both vertical (Masseters, internal 
and temporal Pterygoids) and horizontal (external 
Pterygoids and Buccinators) and consequently 
causes the variation of the lever arm and force 
arm, guiding at the same time the tongue position 
to remain higher and more forward1,20. The new 
posture of the mandible and tongue consequently 
favours an alteration of the position of the hyoid 
bone and of the paravertebral muscles of rachis. 
The lingual ring Ri.P.A.Ra., therefore, influences 
and affects all these components in a more com-
plete manner.
No patient out of the 40 inserted in the PG 
sample has worsened its symptomatology and 
no patient has remained stationary. Thirteen 
patients (33%) declared themselves cured from 
their symptoms and were included in a monitor-
Table II. Control group at T0.
Patients Age Gender Articular  Articular Muscle Head- Cervi- Parafun- Duration
    noises  pains  pains  ache  calgia  ctional  of symp-
         habits    toms
                          (months/
                         years)
11 37 F YES 90 70 50 50 YES  4
 2 45 F YES 0 70 70 0 YES  2
 3 50 F YES 50 50 0 0 YES  1
 4 30 M YES 0 60 60 0 NO  3
 5 27 F YES 0 40 0 40 YES  1
 6 32 F YES 50 0 80 0 YES  3
 7 25 F YES 0 50 50 70 NO  6
 8 28 F YES 30 0 50 0 YES  1
 9 43 F YES 30 0 40 60 YES  1
10 51 F YES 50 50 50 0 NO  4
11 37 F YES 30 0 80 80 YES  1
12 38 F YES 0 60 40 0 YES  2
13 41 F YES 0 80 80 0 NO  3
14 50 F YES 60 0 0 50 YES  1
15 43 M YES 60 0 0 0 YES 9 
16 33 F YES 40 40 40 30 YES  1
17 28 F YES 60 0 0 0 YES  1
18 47 F YES 30 0 0 0 NO 6 
19 42 F YES 50 0 30 20 YES 8 
20 26 F YES 70 0 80 30 NO  1
21 42 F YES 0 70 70 0 YES 8 
22 41 F YES 0 40 50 40 YES  1
23 28 F YES 50 0 50 0 YES  2
24 33 F YES 60 40 0 0 YES  1
25 43 M YES 40 40 40 30 YES  2
26 50 F YES 80 50 0 50 YES 9 
27 43 F YES 80 0 0 0 YES  1
28 38 F YES 0 80 60 0 NO  3
29 37 M YES 0 60 40 70 YES  2
30 51 F YES 30 0 30 0 YES  1
31 44 F YES 50 50 50 90 YES  4
32 28 F YES 30 0 0 0 YES  1
33 25 F YES 30 0 50 0 YES  1
34 32 F YES 0 50 50 70 NO  6
35 27 F YES 50 0 80 0 YES  3
36 29 F YES 0 40 0 40 YES  1
37 51 F YES 0 60 90 0 YES  3
38 46 F YES 50 50 0 0 YES  1
39 38 M YES 0 70 70 0 YES  2
40 31 F YES 40 70 50 50 YES  4
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ing protocol with periodic examinations every 6 
months. Twenty-seven patients (67%) improved 
their symptoms and were treated with other con-
servative conventional methods to complete the 
therapeutic cycle. Therefore, 100% of the PG 
obtained benefits from the application of the new 
therapeutic approach.
In contrast, among patients of CG, eighteen 
subjects (45%) worsened their symptoms, while 
eighteen (45%) were defined as stationaries com-
pared to T0. Only four patients (10%) were defined 
as improved, while no patient was categorized as 
Healed. These results showed an unfavourable 
evolution of the symptoms in patients who were 
not subjected to treatment. This represents a 
further point for reflection on the evaluation of 
the progression of TMDs over time, which is 
still controversial in literature26-32. In our sample, 
only a few untreated subjects improved while the 
majority remained stationary or worsened. All 
subjects of the CG were subsequently inserted in 
a multidisciplinary therapeutic program. 
Table III. Patients group at T1.
Patients Rumor Articular  Muscle Head- Cervi- Para- Duration of
   noises pains ache  calgia  function  symptoms 
        (months/
         years)  Results
 1 NO 0 0 0 0 NO 8 2 G
 2 NO 0 0 0 0 NO 6 1.5 G
 3 NO 0 0 0 0 NO 10 3 G
 4 NO 40 40 40 0 NO 7 2 M
 5 NO 0 30 30 0 NO 5 1.5 M
 6 NO 30 20 20 0 NO 6 1 M
 7 NO 0 0 0 0 YES 8 2.5 M
 8 YES 0 0 50 0 NO 12 3 M
 9 NO 0 0 0 0 YES 10 2 M
10 NO 30 20 0 0 NO 8 2 M
11 NO 0 0 20 0 YES 8 1 M
12 NO 0 0 10 0 NO 4 2 M
13 NO 30 20 0 20 NO 6 2.5 M
14 NO 50 0 0 0 NO 8 3 M
15 NO 0 0 0 0 NO 8 2 G
16 NO 0 0 0 0 NO 7 2 G
17 NO 0 0 50 0 NO 9 1.5 M
18 NO 0 0 0 20 NO 8 2.5 M
19 NO 30 20 0 0 NO 10 2 M
20 NO 0 0 10 0 NO 9 2 M
21 NO 0 0 0 0 NO 8 1 G
22 NO 20 20 20 10 NO 8 2 M
23 NO 0 10 0 0 NO 6 2 M
24 NO 0 20 0 0 NO 4 1 M
25 YES 0 0 20 20 NO 6 3 M
26 NO 0 10 10 10 NO 8 2 M
27 NO 0 0 0 0 NO 10 2 G
28 NO 70 50 20 0 YES 6 2 M
29 NO 30 0 20 0 NO 4 1 M
30 NO 0 0 0 0 NO 5 1 G
31 NO 0 0 20 0 YES 9 2 M
32 NO 0 0 0 0 NO 5 1 G
33 NO 50 20 20 20 NO 6 1 M
34 NO 0 0 0 0 NO 5 1 G
35 NO 0 0 0 0 NO 4 1 G
36 NO 0 10 0 0 YES 6 1 M
37 NO 0 0 0 0 NO 5 1 G
38 NO 0 0 20 0 NO 6 1 M
39 NO 0 0 20 30 NO 8 3 M
40 NO 0 0 0 0 NO 8 2 G
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According to our findings, the Universal Splint 
“Ri.P.A.Ra.” has proven to be a valid garrison for 
immediate treatment. 
Conclusions
After analysing these preliminary data, 
Ri.P.A.Ra present the following advantages: im-
mediacy of use for either patient and operator, 
reduction of waiting times for its application 
compared to other therapeutical approaches (par-
ticularly helpful in public hospitals, with a re-
duction of waiting lists), good tolerability and 
comfort and specificity in the execution of tongue 
rehabilitation exercises. 
In addition, it may be administered to patients 
who underwent rehabilitative dental treatments to 
obtain deconditioning and/or occlusal protection. 
The inconveniences of this new apparatus are 
mainly related to the increased request for col-
laboration from the patient. It is necessary their 
cooperation in learning how to hold the device 
through a different posture of their tongue. Main 
Table IV. Control group at T1.
Patients Rumor Articular  Muscle Head- Cervi- Para- Duration of
   noises pains ache  calgia  function  symptoms 
        (months/
         years)  Results
 1 YES 30 70 50 50 YES  2 S
 2 YES 0 70 70 60 YES  1 P
 3 YES 50 50 0 0 YES  3 S
 4 YES 60 60 80 0 YS  1 P
 5 YES 40 40 100 0 YES  3 P
 6 YES 0 0 60 0 YES  6 S
 7 YES 50 50 50 70 NO  1 S
 8 YES 0 0 50 0 YES  1 M
 9 YES 30 0 70 0 YES  4 S
10 YES 50 50 50 20 YES  1 P
11 YES 30 0 70 0 YES  2 M
12 YES 0 60 40 0 YES  3 S
13 YES 0 80 40 50 NO  1 P
14 YES 80 0 0 50 YES 9  P
15 YES 60 0 60 0 YES  1 P
16 YES 40 40 40 60 YES  2 P
17 YES 60 0 0 0 YES 6  S
18 YES 3 0 50 70 NO 8  S
19 YES 60 0 40 0 NO  1 P
20 YES 60 0 0 0 NO 8  M
21 YES 0 70 70 0 YES  1 S
22 YES 0 40 50 40 YES  2 S
23 YES 50 0 50 0 YES  1 S
24 YES 60 60 0 60 YES  2 P
25 YES 40 40 40 30 YES 9  S
26 YES 80 50 80 50 YES  1 P
27 YES 80 0 0 0 YES  3 S
28 NO 0 80 60 0 NO  2 S
29 YES 0 60 40 100 YES  1 P
30 YES 30 0 80 30 YES  4 P
31 YES 50 50 50 0 YES  1 M
32 YES 30 0 0 0 YES  1 S
33 YES 60 0 50 0 YES  6 P
34 YES 0 50 50 70 NO  3 S
35 YES 70 0 60 0 YES  1 P
36 YES 0 40 0 0 YES  3 S
37 YES 0 60 30 50 NO  1 P
38 YES 80 50 0 0 YES  2 P
39 YES 0 70 70 0 YES  4 S
40 YES 80 70 50 50 YES   P
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Chart 1. Patient group pre-post treatment comparison.
Chart 2. Control group pre-post treatment comparison.
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limitations of this study are represented by the 
small sample and the short period of clinical ob-
servation. Therefore, further studies, with larger 
sample and follow-up are required to confirm our 
findings. 
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